Valsartan And Hydrochlorothiazide
Product Images NDC 53002-2784

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 53002-2784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022784)

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

This text appears to be from a medical evaluation or study. It mentions blood pressure measurements, specifically "DBP<90 (mmHg)" which likely indicates a target diastolic blood pressure value. Additionally, it references different medication dosages, including "Valsartan HCT 320/25 mg" and "Valsartan 320 mg" along with "Hydrochlorothiazide 25 mg" and "Placebo." The text also includes baseline DBP measurements of 95 and 100 (mmHg). This information suggests that the text is related to assessing the effectiveness of certain medications in controlling blood pressure.*

FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.